Literature DB >> 25332157

Oxidative stress is independent of inflammation in the neurodegenerative Sanfilippo syndrome type B.

Stéphanie Trudel1, Eric Trécherel, Cathy Gomila, Maxime Peltier, Michaël Aubignat, Brigitte Gubler, Patrice Morlière, Jean-Michel Heard, Jérôme Ausseil.   

Abstract

Mucopolysaccharidosis (MPS) type IIIB is a genetic deficiency of α-N-acetylglucosaminidase, inducing accumulation of partially degraded heparan sulfate (HS) oligosaccharides in tissues. In the central nervous system, this accumulation is associated with microglial activation, neurodegeneration, and oxidative stress. We have already shown that HS activates microglial cells through toll-like receptor 4 (TLR4) and triggers neuroinflammation. The present study investigates whether oxidative stress is a direct consequence of inflammation or is an independent event directly caused by HS accumulation. The present study addresses causative links between oxidative stress and inflammation by analyzing the corresponding markers in the cortex of control mice, MPSIIIB mice (with neuroinflammation), and double mutant TLR4 knockout MPSIIIB mice (without neuroinflammation at early stages). Results showed that, although inflammation was not present in the cortex of 10-day-old double mutant MPSIIIB/TLR4(-/-) mice, the enzymatic activity of total superoxide dismutase (SOD) was already greater than in control animals. Moreover, at 3 and 8 months of age, the total enzymatic activities of glutathione peroxidase, SOD, and carbonyl protein levels in the cortex of MPSIIIB/TLR4(-/-) mice were similar to those measured in MPSIIIB mice and were higher than those in controls. The results indicate that the oxidative stress present at a very early stage in the brain of MPSIIIB mice is not the consequence of neuroinflammation. Insofar as it has an impact on the development of neurological disease, reducing oxidative stress might prevent or slow the progression of MPSIIIB.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  TLR4; heparan sulfate; inflammation; lysosomal storage diseases; mucopolysaccharidosis; oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 25332157     DOI: 10.1002/jnr.23497

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  10 in total

Review 1.  Oxidative and nitrative stress in neurodegeneration.

Authors:  Catherine A Cobb; Marsha P Cole
Journal:  Neurobiol Dis       Date:  2015-05-27       Impact factor: 5.996

Review 2.  The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy.

Authors:  Anna-Maria Wiesinger; Brian Bigger; Roberto Giugliani; Maurizio Scarpa; Tobias Moser; Christina Lampe; Christoph Kampmann; Florian B Lagler
Journal:  Front Pharmacol       Date:  2022-05-13       Impact factor: 5.988

3.  Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB.

Authors:  N Matthew Ellinwood; Bethann N Valentine; Andrew S Hess; Jackie K Jens; Elizabeth M Snella; Maryam Jamil; Shannon J Hostetter; Nicholas D Jeffery; Jodi D Smith; Suzanne T Millman; Rebecca L Parsons; Mark T Butt; Sundeep Chandra; Martin T Egeland; Ana B Assis; Hemanth R Nelvagal; Jonathan D Cooper; Igor Nestrasil; Bryon A Mueller; Rene Labounek; Amy Paulson; Heather Prill; Xiao Ying Liu; Huiyu Zhou; Roger Lawrence; Brett E Crawford; Anita Grover; Ganesh Cherala; Andrew C Melton; Anu Cherukuri; Brian R Vuillemenot; Jill C M Wait; Charles A O'Neill; Jason Pinkstaff; Joseph Kovalchin; Eric Zanelli; Emma McCullagh
Journal:  J Pharmacol Exp Ther       Date:  2022-06-18       Impact factor: 4.402

Review 4.  Sanfilippo Syndrome: Optimizing Care with a Multidisciplinary Approach.

Authors:  Zuzanna Cyske; Paulina Anikiej-Wiczenbach; Karolina Wisniewska; Lidia Gaffke; Karolina Pierzynowska; Arkadiusz Mański; Grzegorz Wegrzyn
Journal:  J Multidiscip Healthc       Date:  2022-09-19

Review 5.  The role of innate immunity in mucopolysaccharide diseases.

Authors:  Helen Parker; Brian W Bigger
Journal:  J Neurochem       Date:  2018-12-13       Impact factor: 5.372

Review 6.  Molecular Bases of Neurodegeneration and Cognitive Decline, the Major Burden of Sanfilippo Disease.

Authors:  Rachel Heon-Roberts; Annie L A Nguyen; Alexey V Pshezhetsky
Journal:  J Clin Med       Date:  2020-01-27       Impact factor: 4.241

7.  Proteomic Analysis of Mucopolysaccharidosis IIIB Mouse Brain.

Authors:  Valeria De Pasquale; Michele Costanzo; Rosa Anna Siciliano; Maria Fiorella Mazzeo; Valeria Pistorio; Laura Bianchi; Emanuela Marchese; Margherita Ruoppolo; Luigi Michele Pavone; Marianna Caterino
Journal:  Biomolecules       Date:  2020-02-26

Review 8.  Pathogenesis of Mucopolysaccharidoses, an Update.

Authors:  Simona Fecarotta; Antonietta Tarallo; Carla Damiano; Nadia Minopoli; Giancarlo Parenti
Journal:  Int J Mol Sci       Date:  2020-04-04       Impact factor: 5.923

Review 9.  Diagnosis of Mucopolysaccharidoses.

Authors:  Francyne Kubaski; Fabiano de Oliveira Poswar; Kristiane Michelin-Tirelli; Maira Graeff Burin; Diana Rojas-Málaga; Ana Carolina Brusius-Facchin; Sandra Leistner-Segal; Roberto Giugliani
Journal:  Diagnostics (Basel)       Date:  2020-03-22

Review 10.  Novel therapies for mucopolysaccharidosis type III.

Authors:  Berna Seker Yilmaz; James Davison; Simon A Jones; Julien Baruteau
Journal:  J Inherit Metab Dis       Date:  2020-09-28       Impact factor: 4.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.